| UBQLN4 — Ubiquilin 4 | |
|---|---|
| Symbol | UBQLN4 |
| Full Name | Ubiquilin 4 |
| Chromosome | Xq24 |
| NCBI Gene | 94160 |
| Ensembl | ENSG00000163527 |
| OMIM | 300368 |
| UniProt | Q9Y5X5 |
| Diseases | ALS, FTD |
| Expression | Motor cortex, Hippocampus, Cerebellum |
| Key Mutations | |
| P497S, T187fs, R198X | |
UBQLN4 (Ubiquilin 4) is a gene located on chromosome Xq24 that encodes a member of the ubiquilin family of proteins involved in protein quality control and degradation pathways. Mutations in UBQLN4 have been increasingly recognized as important contributors to neurodegenerative diseases, particularly amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). This gene encodes a protein that plays critical roles in targeting misfolded proteins for proteasomal and autophagic degradation, making it essential for maintaining neuronal proteostasis.
The ubiquilin family (UBQLN1, UBQLN2, UBQLN3, UBQLN4, and UBQLNL in humans) shares a common architecture featuring an N-terminal ubiquitin-like (Ubl) domain and a C-terminal ubiquitin-associated (UBA) domain, connected by a variable middle region containing multiple stiff-chain (STI) motifs. UBQLN4, also known as UBIN or GIDE, is particularly enriched in the brain and has been implicated in both autosomal dominant and recessive forms of neurodegeneration[1].
UBQLN4 is a 624-amino acid protein that serves as a molecular adaptor linking ubiquitinated proteins to the proteasome and autophagy machinery. The gene is catalogued as NCBI Gene ID 94160 and OMIM 300368. UBQLN4 is expressed throughout the brain with high expression in motor cortex, hippocampus, and cerebellum — regions prominently affected in ALS and FTD[2]. The protein localizes to the cytoplasm and nucleus, where it participates in various protein quality control pathways. Dysfunction of UBQLN4 leads to accumulation of ubiquitinated protein aggregates, a hallmark pathology observed in most neurodegenerative diseases.
The UBQLN4 protein contains several functionally important domains:
The N-terminal Ubl domain adopts a β-grasp fold similar to ubiquitin and is involved in binding to proteasome subunits. This domain facilitates the delivery of ubiquitinated substrates to the 26S proteasome for degradation. The Ubl domain also interacts with autophagy receptors, enabling selective autophagy pathways[3].
The middle region of UBQLN4 contains multiple STI1 (Stress-Induced Phosphoprotein 1) repeat motifs. These coiled-coil domains mediate protein-protein interactions and are crucial for forming homomeric and heteromeric complexes with other ubiquilin family members. The STI1 domains also interact with various client proteins, including RNA-binding proteins and mitochondrial proteins[4].
The C-terminal UBA domain binds monoubiquitin and polyubiquitin chains of various linkages. This domain recognizes ubiquitinated substrates and targets them for degradation. The UBA domain also interacts with valosin-containing protein (VCP/p97), an AAA+ ATPase involved in extracting ubiquitinated proteins from membranes and protein complexes for proteasomal degradation[5].
UBQLN4 plays a central role in the cellular protein quality control network. As a ubiquitin-binding adaptor protein, it recognizes misfolded or damaged proteins that have been tagged with ubiquitin chains. UBQLN4 then facilitates the delivery of these substrates to either the 26S proteasome for degradation or to autophagy receptors for lysosomal degradation. This function is particularly important in neurons, which are long-lived cells with limited regenerative capacity[6].
Through its Ubl domain, UBQLN4 binds to the 19S regulatory particle of the 26S proteasome. This interaction delivers ubiquitinated substrates to the proteasome for unfolding and degradation. UBQLN4 can also shield substrates from deubiquitinating enzymes, preserving the ubiquitin signal for proteasomal recognition[7].
UBQLN4 interacts with autophagy receptors such as p62/SQSTM1 and OPTN through its UBA domain. These interactions link UBQLN4 to selective autophagy pathways including mitophagy (mitochondrial autophagy), aggrephagy (aggregate autophagy), and ribophagy. UBQLN4 can be itself degraded by autophagy, suggesting a role in autophagic flux regulation[8].
The interaction between UBQLN4 and VCP/p97 is critical for extracting ubiquitinated proteins from membranes, protein complexes, and chromatin. This extraction process, also known as ubiquitination-dependent protein extraction (UDPE), is essential for protein turnover, DNA repair, and stress response. Mutations affecting VCP cause inclusion body myopathy with early-onset Paget disease of bone and frontotemporal dementia (IBMPFD), highlighting the importance of this pathway in neurodegeneration[9].
UBQLN4 is widely expressed throughout the human brain with particularly high levels in:
Expression data from the Allen Human Brain Atlas confirms these regional patterns, with UBQLN4 mRNA detected in both neurons and glial cells[10].
Within neurons, UBQLN4 localizes to:
UBQLN4 mutations were first linked to ALS in 2018 when dominant missense and frameshift mutations were identified in familial ALS patients. The P497S mutation, located in the STI1 domain, is the most frequently reported pathogenic variant[11].
Disease Mechanisms:
UBQLN4 mutations also cause FTD, particularly the behavioral variant (bvFTD). The disease mechanisms overlap substantially with ALS, reflecting the clinicopathological continuum between these disorders.
Pathological Features:
While most strongly associated with ALS and FTD, UBQLN4 dysfunction may contribute to:
| Mutation | Type | Domain | Clinical Phenotype |
|---|---|---|---|
| P497S | Missense | STI1 | ALS, FTD |
| T187fs | Frameshift | STI1 | ALS (recessive) |
| R198X | Nonsense | STI1 | ALS (recessive) |
| G183R | Missense | STI1 | FTD |
| K207R | Missense | STI1 | ALS |
The P497S mutation is the most studied and affects UBQLN4's ability to interact with VCP and proteasome subunits. Recessive mutations (T187fs, R198X) likely cause disease through loss-of-function mechanisms[14].
UBQLN4 interacts with numerous proteins involved in protein quality control and neurodegeneration:
The study of Ubqln4 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Page auto-generated and expanded from NeuroWiki gene database. Last updated: 2026-03-06.